Back
Results - Announcements
Sales decline 15.49% to Rs 10.80 crore
Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter
13-Jan-2025, 07:32
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended | ||
Dec. 2024 | Dec. 2023 | % Var. | |
Sales | 10.80 | 12.78 | -15 |
OPM % | 12.87 | 4.93 | - |
PBDT | 0.90 | 0.13 | 592 |
PBT | 0.53 | -0.26 | LP |
NP | 0.23 | -0.24 | LP |
Powered by Capital Market - Live News